Kirk D. Schumacher
Keine laufenden Positionen mehr
Karriereverlauf von Kirk D. Schumacher
Ehemalige bekannte Positionen von Kirk D. Schumacher
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | General Counsel | - | 01.09.2023 |
| SEAGEN INC. | Compliance Officer | 01.10.2003 | 26.11.2014 |
| General Counsel | 03.06.2009 | 26.11.2014 | |
| Kds Law Group | Corporate Officer/Principal | - | - |
Venture Law Group
 Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Kirk D. Schumacher
| University of Wisconsin | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 2 |
| General Counsel | 2 |
| Compliance Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Venture Law Group
Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Commercial Services |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Kds Law Group |
- Börse
- Insiders
- Kirk D. Schumacher
- Erfahrung
